Literature DB >> 14570710

Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

Laura Kennedy1, Elizabeth Evans, Chiung-Mei Chen, Lyndsey Craven, Peter J Detloff, Margaret Ennis, Peggy F Shelbourne.   

Abstract

Huntington disease is caused by the expansion of a CAG repeat encoding an extended glutamine tract in a protein called huntingtin. Although the mutant protein is widely expressed, the earliest and most striking neuropathological changes are observed in the striatum. Here we show dramatic mutation length increases (gains of up to 1000 CAG repeats) in human striatal cells early in the disease course, most likely before the onset of pathological cell loss. Studies of knock-in HD mouse models indicate that the size of the initial CAG repeat mutation may influence both onset and tissue-specific patterns of age-dependent, expansion-biased mutation length variability. Given that CAG repeat length strongly correlates with clinical severity, we suggest that somatic increases of mutation length may play a major role in the progressive nature and cell-selective aspects of both adult-onset and juvenile-onset HD pathogenesis and we discuss the implications of this interpretation of the data presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570710     DOI: 10.1093/hmg/ddg352

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  137 in total

1.  Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat.

Authors:  Mário Gomes-Pereira; Darren G Monckton
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

Review 2.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 3.  DNA base excision repair: a mechanism of trinucleotide repeat expansion.

Authors:  Yuan Liu; Samuel H Wilson
Journal:  Trends Biochem Sci       Date:  2012-01-27       Impact factor: 13.807

4.  Role of glutamine deamidation in neurodegenerative diseases associated with triplet repeat expansions: a hypothesis.

Authors:  Qurratulain Hasan; Ravindra Varma Alluri; Pragna Rao; Yog Raj Ahuja
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

5.  OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells.

Authors:  Irina V Kovtun; Yuan Liu; Magnar Bjoras; Arne Klungland; Samuel H Wilson; Cynthia T McMurray
Journal:  Nature       Date:  2007-04-22       Impact factor: 49.962

Review 6.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

7.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

Review 8.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

9.  Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients.

Authors:  Vera I Hashem; Malgorzata J Pytlos; Elzbieta A Klysik; Kuniko Tsuji; Mehrdad Khajavi; Merhdad Khajav; Tetsuo Ashizawa; Richard R Sinden
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

10.  Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.

Authors:  Catherine F Higham; Darren G Monckton
Journal:  J R Soc Interface       Date:  2013-09-18       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.